# name
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders

# metadata.dc.description.abstract[].value
Research in recent years on peroxisome proliferator-activated receptor (PPAR)β/δ indicates that it plays a key role in the maintenance of energy homeostasis, both at the cellular level and within the organism as a whole. PPARβ/δ activation might help prevent the development of metabolic disorders, including obesity, dyslipidaemia, type 2 diabetes mellitus and non-alcoholic fatty liver disease. This review highlights research findings on the PPARβ/δ regulation of energy metabolism and the development of diseases related to altered cellular and body metabolism. It also describes the potential of the pharmacological activation of PPARβ/δ as a treatment for human metabolic disorders

# metadata.dc.relation.ispartof[].value
International Journal of Molecular Sciences, 2018, vol. 19, num. 3, p. 913

# metadata.dc.rights[].value
cc-by (c) Palomer Tarridas, Francesc Xavier et al., 2018

# metadata.dc.source[].value
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

# metadata.dc.title[].value
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders